0001127602-17-011763.txt : 20170315 0001127602-17-011763.hdr.sgml : 20170315 20170315152303 ACCESSION NUMBER: 0001127602-17-011763 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170313 FILED AS OF DATE: 20170315 DATE AS OF CHANGE: 20170315 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edge Therapeutics, Inc. CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Faleck Herbert J CENTRAL INDEX KEY: 0001652994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 17691062 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1600 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-03-13 0001472091 Edge Therapeutics, Inc. EDGE 0001652994 Faleck Herbert J 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 1 Chief Medical Officer Stock Option (right To Purchase) 8.86 2017-03-13 4 A 0 110000 8.86 A 2027-03-13 Common Stock 110000 110000 D This option, representing a right to purchase a total of 110,000 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. /s/ Albert N. Marchio II, attorney-in-fact 2017-03-15